S
Saranas
Saranas develops a medical device that detects internal bleeding during catheterization procedures
About Saranas
Saranas, Inc. operates in the medical device industry, specializing in innovative bleed detection systems. The company's flagship product, the Early Bird, is the first and only FDA-approved system designed for peri and post-procedural monitoring of endovascular procedures. This system provides clinicians with accurate and actionable information to detect internal bleeds early, thereby mitigating the detrimental consequences associated with bleeding complications. Saranas primarily serves healthcare providers, including hospitals and clinics, that perform large bore endovascular procedures. The company generates revenue through the sale of its Early Bird system and related services. By addressing a critical need in the medical field, Saranas aims to improve patient outcomes and reduce healthcare costs associated with bleed complications.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Houston, United States
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 67.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jul 2021 | $13M | $51M | Robert W. Baird & Co. · Baird Capital · S3 Ventures | — |
| SERIES C✓Equity / VC | May 2018 | $2.8M | $11M | Undisclosed | — |
Growth signals
Latest recorded traffic for Saranas is 280 monthly website visits, down 15.2% over the last three months. Saranas's team declined 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Houston Angel Network
Robert W. Baird & Co.
Baird Capital
S3 Ventures
Other known investors3 additional known investors
Texas Heart Institute- GCGOOSE Capital
- TVTexas Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Saranas on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Saranas’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.